Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7VB0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,353
Award facts
- Contract value 100% obligated
- $59,352.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,352.62 on January 12, 2026, by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and operates under a non-competitive set-aside designation. This award represents a task order placed against AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
The delivery of Ozempic, a diabetes medication, aligns with AmerisourceBergen's established role as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive pharmaceutical portfolio under its DLA contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific award demonstrates the company's continued capacity to fulfill federal requirements for essential pharmaceutical commodities through the DLA Medical Supply Chain, supporting Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7VB0?
SPE2DR26F7VB0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F7VB0 worth?
The government has obligated $59,353 on SPE2DR26F7VB0.
Is contract SPE2DR26F7VB0 an order under another contract?
Yes. SPE2DR26F7VB0 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VB0 competed?
The extent of competition for SPE2DR26F7VB0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award